Regional players like Nobel Ilac and Abdi Ibrahim appear frequently among the top 50 highest selling products. Their portfolio centers on affordable treatments for common conditions purchased directly by consumers.

Multinationals Pharmaceutical Companies Target Kazakhstan Through Tenders, Locals Lead Retail 

However, these retail figures fail to capture government procurement via tenders. In this national marketplace, global giants may move more product volume. Multinationals possess the technology, research expertise and innovative new drugs that public health agencies desire.

Kazakhstan is actively working to upgrade its healthcare infrastructure as the economy develops. This involves a balancing act between meeting current basic needs through low cost generics while also planning for more advanced care down the road. There exists ample room for both international brands and local stalwarts if steady growth continues.

Essentially, global pharmaceutical companies use tenders to tap higher value segments while established regional companies supply current retail demand. A dual market is emerging as the future brightens for healthcare advancements across Kazakhstan.  

Top 50 Pharmaceutical Products in Kazakhstan for January 2024 (table)

About the Author

Ainur Abdullayeva

is a healthcare journalist and medical writer at Mister Blister, based in Almaty. With a medical degree from Kazakh National Medical University, she specializes in demystifying complex topics like pharmaceutical regulations and drug development. Ainur provides insights into the evolving healthcare landscape across Central Asia, including pharmaceutical marketing strategies and traditional Kyrgyz medicine.